Dr. Reddy's Ranitidine Tablets, USP 75 mg, 60 count bottles, NDC 55111-131-60, (OTC)

Recall Number: D-0181-2020

Firm: Dr. Reddy's Laboratories, Inc.

Classification: Class II

Status: Completed

Report Date: 20191113

Initiation Date: 20191001

Termination Date:

Reason for Recall

CGMP Deviations: Presence of NDMA impurity detected in product.

Product Description

Dr. Reddy's Ranitidine Tablets, USP 75 mg, 60 count bottles, NDC 55111-131-60, (OTC)